Relugolix is a gonadotropin-releasing hormone (GnRH) receptor antagonist used to treat advanced prostate cancer. It works by blocking the production of testosterone, which is essential for the growth of prostate cancer cells. Relugolix is effective in managing advanced prostate cancer. In summary, Relugolix is beneficial for treating hormone-sensitive prostate cancer.
Relugolix inhibits GnRH receptors, leading to decreased testosterone production and reduced stimulation of prostate cancer cells.